Back to company

Compact Biomedical ApS: Financial statements 2020

CVR: 32780601

Compact Biomedical ApS (CVR 32780601) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,101 and a net result of DKK -4,266,584 compared with DKK -1,135,854 the year before. Equity amounted to DKK 519,412. The solvency ratio was 7.8%.

Gross Profit
-6,101 kr.
Profit/Loss
-4,266,584 kr.
Equity
519,412 kr.
Total Assets
6,640,885 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--6 t.-4.3 mio.519 t.-
2019--6 t.-1.1 mio.4.8 mio.-
2018--5 t.-964 t.5.9 mio.-
2017--5 t.-1 mio.6.9 mio.-
2016--5 t.1.7 mio.7.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Compact Biomedical ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Compact Biomedical ApS: The 2019 annual report is outMay 13, 2020

Compact Biomedical ApS has published its annual report for 2019. Gross profit came to DKK -6,126, and the net result was DKK -1,135,854.

About Compact Biomedical ApS

Compact Biomedical ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Sten Velschow. The company is owned by Sten Velschow. In 2025, the company reported a gross profit of DKK 60,971 and a net result of DKK 48,494 compared with DKK -36,656 the year before. Equity amounted to DKK -81,224.